Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression

Figure 2 Effect of glyceraldehyde-derived advanced glycation end-products on the viability of hepatocellular carcinoma cells. Cell viability was determined using the WST-8 assay. Hep3B (A) and HepG2 (B) cells were incubated with control unglycated bovine serum albumin (BSA) or glyceraldehyde-derived advanced glycation end-products (Glycer-AGEs) (100 μg/mL) for 24 h. The open and filled bars represent results for cells treated with control unglycated BSA and Glycer-AGEs, respectively. Data are shown as the mean ± SD (n = 6).